Literature DB >> 4559027

Effect of tyramine in migraine: a double-blind study.

A Moffett, M Swash, D F Scott.   

Abstract

The incidence of headache and changes in the EEG after tyramine were studied in 25 migrainous patients in a double-blind placebo-controlled investigation. There were three groups of patients: the first had migraine alone, the second had migraine and epilepsy, and the third had migraine which was precipitated by food substances containing tyramine. Psychological tests showed that all the patients were more neurotic, more introverted, and more obsessional than normal subjects. Headache occurred in 12 of 50 patient sessions and 10 of these occurred in the group with dietary precipitated migraine. In this group, however, headache followed tyramine alone in only two patients. The remaining eight headaches occurred in two patients after placebo alone, and in three after both test capsules. The EEG was activated after tyramine, but not after placebo, in 11 of the 15 patients with migraine and epilepsy, and dietary precipitated migraine. This effect was observed, however, in only two of the 10 patients with classical migraine alone. There was no relation between the occurrence of headache and EEG activation. Although there was no significant relationship between tyramine ingestion and the occurrence of headache, the EEG changes observed during the study support the hypothesis that tyramine has an action on the central nervous system in some migrainous subjects.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4559027      PMCID: PMC494110          DOI: 10.1136/jnnp.35.4.496

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  MONOAMINE OXIDASE INHIBITORS: AUGMENTATION OF PRESSOR EFFECTS OF PERORAL TYRAMINE.

Authors:  D H TEDESCHI; E J FELLOWS
Journal:  Science       Date:  1964-06-05       Impact factor: 47.728

2.  INTERACTION BETWEEN CHEESE AND MONOAMINE-OXIDASE INHIBITORS IN RATS AND CATS.

Authors:  B BLACKWELL; E MARLEY
Journal:  Lancet       Date:  1964-03-07       Impact factor: 79.321

3.  PSYCHOLOGICAL AND CLINICAL INVESTIGATION OF THE TREATMENT OF ANXIOUS OUT-PATIENT WITH THREE BARBITURATES AND PLACEBO.

Authors:  E REYNOLDS; C R JOYCE; J L SWIFT; P H TOOLEY; M WEATHERALL
Journal:  Br J Psychiatry       Date:  1965-01       Impact factor: 9.319

4.  EEG criteria of hypocalcaemia and hypercalcaemia.

Authors:  M Swash; A J Rowan; D F Scott
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1971-04

5.  Conjugation defect in tyramine-sensitive migraine.

Authors:  M B Youdim; S B Carter; E Hanington; M Wilkinson; M Sandler
Journal:  Nature       Date:  1971-03-12       Impact factor: 49.962

6.  Some clinical and EEG findings in patients with migraine.

Authors:  K H Slatter
Journal:  Brain       Date:  1968-03       Impact factor: 13.501

7.  Migraine--research.

Authors:  J N Blau
Journal:  Br Med J       Date:  1971-06-26

8.  The relation of migraine and epilepsy.

Authors:  L S Basser
Journal:  Brain       Date:  1969       Impact factor: 13.501

9.  Preliminary report on tyramine headache.

Authors:  E Hannington
Journal:  Br Med J       Date:  1967-05-27

10.  The Leyton obsessional inventory.

Authors:  J Cooper
Journal:  Psychol Med       Date:  1970-11       Impact factor: 7.723

View more
  7 in total

Review 1.  Treating migraine.

Authors:  C Clough
Journal:  BMJ       Date:  1989-07-15

2.  Editorial: Biochemical basis of migraine.

Authors: 
Journal:  Br Med J       Date:  1974-11-09

3.  Cranial arteralgias.

Authors: 
Journal:  Br Med J       Date:  1973-01-20

Review 4.  The role of food in the pathogenesis of migraine headache.

Authors:  T R Vaughan
Journal:  Clin Rev Allergy       Date:  1994

5.  Effect of chocolate in migraine: a double-blind study.

Authors:  A M Moffett; M Swash; D F Scott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

6.  The challenge of unexplained diseases: migraine.

Authors:  J N Blau
Journal:  J R Soc Med       Date:  1992-10       Impact factor: 18.000

7.  Do Molecular Structures of Migraine Drugs Point to a Common Cause of this Elusive Disease and Suggest Future Drug Designs?

Authors:  Mark J Brinsden; Ian C Shaw
Journal:  Pharmaceut Med       Date:  2015
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.